Welcome to CDC stacks | Methods for sexually transmitted disease prevention programs to estimate the health and medical cost impact of changes in their budget - 53606 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Methods for sexually transmitted disease prevention programs to estimate the health and medical cost impact of changes in their budget
  • Published Date:
    Jan 2018
  • Source:
    Sex Transm Dis. 45(1):2-7
  • Language:
    English
Filetype[PDF-475.57 KB]


Details:
  • Pubmed ID:
    29240632
  • Pubmed Central ID:
    PMC5905677
  • Description:
    Background

    The purpose of this paper was to describe methods that sexually transmitted disease (STD) programs can use to estimate the potential effects of changes in their budgets in terms of disease burden and direct medical costs.

    Methods

    We proposed two distinct approaches to estimate the potential effect of changes in funding on subsequent STD burden, one based on an analysis of state-level STD prevention funding and gonorrhea case rates and one based on analyses of the effect of Disease Intervention Specialist (DIS) activities on gonorrhea case rates. We also illustrated how programs can estimate the impact of budget changes on intermediate outcomes, such as partner services. Finally, we provided an example of the application of these methods for a hypothetical state STD prevention program.

    Results

    The methods we proposed can provide general approximations of how a change in STD prevention funding might affect the level of STD prevention services provided, STD incidence rates, and the direct medical cost burden of STDs. In applying these methods to a hypothetical state, a reduction in annual funding of $200,000 was estimated to lead to subsequent increases in STDs of1.6% to 3.6%. Over 10 years, thereduction in funding totaled $2.0 million, whereas the cumulative, additional direct medical costs of the increase in STDs totaled $3.7 to $8.4 million.

    Conclusions

    The methods we proposed, though subject to important limitations, can allow STD prevention personnel to calculate evidence-based estimates of the effects of changes in their budget.

  • Document Type:
  • Collection(s):
No Related Documents.
You May Also Like: